Airlines are known for their quick and effective social media responses, often helping stranded and annoyed passengers in real time. But while pharma companies can't solve problems instantly with a reroute or seat change, they can definitely look to airline's social media savvy for inspiration, one industry consultant says.
It's deja vu for the pharma industry. Mylan's EpiPen pricing controversy - kicked into high gear with mainstream media coverage of widespread outrage - has revived public and political fury against drug companies.
The FDA has placed four Chinese and Indian generic drug facilities on the so-called "Red List" that bans them from shipping products to the U.S. for failing to pay required fees and not meeting identification requirements.
More and more drug makers are giving continuous manufacturing a try, seeing it as the future in small molecule drug production, in part, because the plants for the process are much smaller than those for batch processing. Now, scientists at MIT have a prototype of a continuous manufacturing device so small it might be used by pharmacies to produce their own generic drugs.